Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Express Scripts
Medtronic
Baxter
McKesson

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Plitidepsin

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Plitidepsin: Sponsors, patents, clinical trial progress

Plitidepsin is an investigational drug.

There have been 11 clinical trials for Plitidepsin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2010.

The most common disease conditions in clinical trials are Neoplasms, Plasma Cell, Multiple Myeloma, and Lymphoma. The leading clinical trial sponsors are PharmaMar, Institut Bergonié, and Ministry of Health, France.

There are two US patents protecting this investigational drug and thirty-six international patents.

Recent Clinical Trials for Plitidepsin
TitleSponsorPhase
Trial of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Patients Double Refractory to Bortezomib and LenalidomidePharmaMarPhase 2
A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell LymphomaPharmaMarPhase 2
Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple MyelomaPharmaMarPhase 1

See all Plitidepsin clinical trials

Clinical Trial Summary for Plitidepsin

Top disease conditions for Plitidepsin
Top clinical trial sponsors for Plitidepsin

See all Plitidepsin clinical trials

US Patents for Plitidepsin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Plitidepsin   Start Trial Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them Pharma Mar, S.A. (Madrid, ES)   Start Trial
Plitidepsin   Start Trial Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them Pharma Mar, S.A. (ES)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Plitidepsin

Drugname Country Document Number Estimated Expiration Related US Patent
Plitidepsin Austria 393775 2020-06-30   Start Trial
Plitidepsin Australia 6769801 2020-06-30   Start Trial
Plitidepsin Brazil 0112375 2020-06-30   Start Trial
Plitidepsin Canada 2414609 2020-06-30   Start Trial
Plitidepsin China 101575363 2020-06-30   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Moodys
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.